Clene Inc. (CLNN) vs Microbot Medical Inc. (MBOT)

A side-by-side comparison of Clene Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLNN vs MBOT

growth of $100 · dividends reinvested · last 8y
CLNN -98.0% (-38.7%/yr)MBOT -81.3% (-18.9%/yr)MBOT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$2$19
CLNN MBOT

CLNN vs MBOT: by the numbers

  • •CLNN is the larger company ($49M vs $49M market cap).
  • •Both run net losses; MBOT's is the smaller (-4722.25% vs -20059.90% net margin).

Metrics side by side

Valuation

MetricCLNNMBOT
P/S ratio251.03140.75
P/B ratioN/A0.71

Profitability

MetricCLNNMBOT
Gross margin78.50%0.00%
Operating margin-11541.50%0.00%
Net margin-20059.90%-4722.25%
ROEN/A-23.70%
ROIC-109.13%-26.51%

Growth (annualized)

MetricCLNNMBOT
Revenue CAGR (5Y)-18.30%N/A
Total return CAGR (5Y)-51.16%-31.63%

Frequently asked

How have CLNN and MBOT total returns compared?
Over the past 5 years, CLNN delivered -51.16% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.